Large Biopharma

Adapt, innovate, and scale for the future

At a turning point in clinical trial transformation, large biopharma companies rely on Medidata to adapt, scale, and realize their next breakthrough.

Large Biopharma
Adapt, innovate, and scale for the future

Why Large Biopharma Companies Trust Medidata

Large biopharma players are under pressure to adapt to disruptions, respond to patient centricity, detect risks earlier, and scale at an unprecedented pace to get therapies to market faster.

With 20+ years of industry leadership, Medidata empowers 19 of the top 20 biopharma companies to meet the demands and opportunities of every trial environment.

Innovate with Proven Technology

Unify the latest digital technologies, new data sources, and advanced analytics, to realize your next breakthrough and propel your growth.

Adapt To Anything

Respond to changing needs or new opportunities. Adapt to new challenges, integrate new technologies, and meet patient expectations.

Build For the Future

Stay ahead of new disruptions, trends, and innovations. Invest in the technology that meets today’s opportunities and tomorrow’s transformation.

One technology platform to power people, processes, and progress.

The industry’s only complete decentralized clinical trial solution

You don’t just need a decentralized clinical trial solution. You need a partner who understands your specific needs as a large Biopharma and has proven capabilities with large studies, a completely unified platform, and offers data security, privacy, and compliance.

Truth in data:

  • 800+ studies, 600K+ patients, 44K+ sites using a Medidata DCT solution
  • All top 10 pharma have used Medidata’s DCT solutions

Read more about our end-to-end decentralized clinical trials for large biopharma.

The industry’s only platform to leverage cross-industry clinical trial data

You operate in a high risk, continuously evolving clinical development landscape. Navigate that landscape with actionable insights and data-driven decisions for safer, stronger, and better clinical trials.

Truth in data:

  • Clinical trial data from 7 million patients and 25,000+ trials
  • 45B+ data points
  • 63% growth in data volume in 4 years

Learn more about our data and analytics solutions for large biopharma.

The results-driven approach to unifying teams, data, and processes

Outgrown your current IT infrastructure? For large biopharma, Medidata offers a solution flexible enough to work with your existing systems and powerful enough to ingest new data sources, decentralizing elements of your trial with ease – so you can quickly optimize trial performance.

Truth in data:

  • 5 days to reach database lock
  • 80% reduction in data correction rates
  • 40% reduction in edit checks

Learn more about our unified technology platform for large biopharma.

The industry’s most comprehensive patient-centric solutions

For large biopharma, trial success hinges on finding the right patients and keeping them engaged pre, during, and post trial. Our patient-centric solutions reduce patient burden, increase patient safety, and drive patient diversity – with a seamless, intuitive, and accessible patient experience.

Truth in data:

  • Cross-industry clinical trial data from over 25,000 trials and over 7 million patients
  • Datasets pre-integrated with real world data

Learn more about our patient-centric clinical trial solutions for large biopharma.

Contact Sales